Navigation Links
Variable gene expression in zebrafish
Date:4/28/2014

This news release is available in German.

Early embryonic development of vertebrates is controlled by the genes and their "grammar". Decoding this grammar might help understand the formation of abnormalities or cancer or develop new medical drugs. For the first time, it is now found by a study that various mechanisms of transcribing DNA into RNA exist during gene expression in the different development phases of zebrafish. This study is presented by KIT researchers in the journal "Nature".

After several genomes have been sequenced and human genetic material has been decoded, many questions regarding the structure and function of genetic information still remain unanswered. On the DNA (deoxyribonucleic acid), the carrier of genetic information, scientists search for the grammar regulating gene expression, for instance. The result of this gene expression is the RNA (ribonucleic acid) that converts genetic information into proteins. A major pro-cess of gene expression is transcription, by which RNA is synthe-sized according to a DNA template. However, it is still unknown where exactly transcription starts and which regularly recurring DNA segments, DNA modifications or structural modifications of the DNA are required to determine the start of transcription. Complete understanding of transcription regulation might allow for specific interference with these mechanisms and the development of new medical drugs against diseases.

An international team of scientists, including Uwe Strhle, Head of the Institute of Toxicology and Genetics (ITG) of KIT, and his staff members Dr. Olivier Amant and Dr. Marco Ferg, studied the pro-cesses associated with the start of transcription in zebrafish in more detail. The ITG runs the European Zebrafish Resource Center (EZRC), a central archive for fish cultivation and dissemination and screening center. In genetics, the zebrafish is considered an im-portant model organism for studies of vertebrates. Using the CAGE (Cap Analysis of Gene Expression) high-throughput method, the scientists determined the starting points of transcription of many thousands of genes in various phases of embryonic development of zebrafish.

Comparison of the data revealed that use of certain starting points differs in two phases of embryonic development in particular: Before and after activation of the embryonic genome. "Prior to activation, the growing embryo uses transcripts deposited by the mother in the egg for the production of proteins," explains Dr. Marco Ferg, ITG. "The genome of the mother acts as a matrix or complementary template. After activation of the embryonic genome, the transcripts are newly produced. Then, the genome of the embryo serves as a matrix." With the help of so-called next-generation sequencing methods for decoding unknown DNA sequences at high throughputs, the ITG researchers were the first to find out that various transcription mechanisms exist in various development phases.

Further studies are needed to determine whether the specific use of transcription starting points is a widely disseminated mechanism for gene regulation. "If this is the case, it might be possible to control transcription and to specifically counteract diseases like cancer, which are caused by defective transcription," Marco Ferg says. "However, we are still in the phase of fundamental research."


'/>"/>

Contact: Monika Landgraf
presse@kit.edu
49-721-608-47414
Karlsruher Institut fr Technologie (KIT)
Source:Eurekalert  

Related medicine news :

1. Price for hip replacement highly variable, hard to obtain
2. PCa markers improve predictive performance of existing clinical variables
3. Chicago Digital Printer Introduces Variable-Data Printing for Bulk iPhone Case Orders
4. Variable Valve Timing & Start-Stop Systems Market is Estimated to Grow at Highest CAGR of 16.43% from 2013 to 2018 – New Report by MarketsandMarkets
5. Variable Valve Timing Market and Start-Stop Systems is poised to grow up to 88.8 Million units and $9.8 Billion by 2018 - New Report by MarketsandMarkets
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Control of gene expression: Histone occupancy in your genome
8. Overexpression of proteins 14-3-3 related to chemotherapy resistance
9. Gene expression test identifies low-risk thyroid nodules
10. Gene expression improves the definition of a breast cancer subtype
11. Synthetic circuit allows dialing gene expression up or down in human cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Variable gene expression in zebrafish
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: